Boston Millennia Partners

Contact Us | Site Map | Search | Client Login


	Our Firm

	Our Team

	Our Portfolio

	Investment Performance

	Resources

	News

	Meet With The Team



			Dana Callow Managing General Partner Read More...



			Dana Callow Managing General Partner



	Richard Love from ILEX Oncology, Inc. on Boston Millennia Partners...




	Boston Millennia Partners provides private equity financing to high growth companies in the healthcare and life sciences industry. Our team brings over one hundred years of combined private equity experience to the investment process. Our broad experience, combined with expertise in finance; operations; engineering; life sciences research and development; partnering with pharmaceutical companies; business development; executive recruiting; and law provides significant value to the companies in which we invest. Since the early 1980’s, members of our team have managed seven venture capital partnerships with very successful results for our investors and our entrepreneurs. The growth and success of our portfolio companies have, in turn, allowed us to grow and expand our capital base to over $700 million under management.

Boston Millennia Partners is pleased to announce that its portfolio company, CardioMEMS, Inc., an Atlanta based medical device company, has accepted a $60 million investment from and granted a $375 million purchase option to St. Jude Medical, Inc.

"The CardioMEMS CHAMPION Heart Failure System has demonstrated superb clinical, quality of life and cost reduction potential for CHF patients. St. Jude Medical is an excellent partner with whom this technology can be brought to market promptly, improving clinical prospects for patients and cost of care for payers." says Patrick Fortune PhD, a partner at Boston Millennia Partners and member of the CardioMEMS Board of Directors.

MedAptus First Again in KLAS Mobile Data Systems Rankings Boston Millennia portfolio company, MedAptus, was named first in KLAS Mobile Data Systems Rankings. MedAptus' top-ranking score in the "2011 Best in KLAS Awards: Software & Services" report is based on positive customer feedback for the second year in a row. Learn More >
	Next >

me2me AG and MedAptus Partner to Provide Advanced Mobile Charge Capture, Dictation and Workflow Solutions to Physician Groups Boston Millennia portfolio company, MedAptus, has partnered with me2me AG, a software company delivering mobile dictation, transcription and speech recognition solutions. Learn More >
< Previous	Next >

Parexel International Releases 2011 Annual Report Boston Millennia's Strategic Partner, Parexel International, released their 2011 Annual Report detailing favorable progress over the year. Learn More >
< Previous	Next >

Dana Callow Elected to National Board of Directors of the Leukemia & Lymphoma Society Boston Millennia Partners Managing General Partner, Dana Callow, was elected to the Board of Directors of the Leukemia & Lymphoma Society. LLS is the largest voluntary health agency dedicated to blood cancer. Learn More >
< Previous	Next >

Millennia Portfolio Company, MedAptus�, Names Dr. Ryan Secan Chief Medical Officer MedAptus�, the market leader for charge capture technologies, announced that Dr. Ryan A. Secan, has joined the company as Chief Medical Officer. Dr. Secan is currently a practicing hospitalist at Emerson Hospital in Concord, MA. Learn More >
< Previous	Next >

PAREXEL International Named Company Of The Year For The Pharmaceutical Industry Boston Millennia Strategic Partner, PAREXEL International Corp., has been named Company of the Year for the Pharmaceutical Industry in The Eighth Annual International Business Awards. Learn More >
< Previous	Next >

CardioMEMS Founder & CEO Dr. Jay Yadav Named Ernst & Young Entrepreneur of the Year� Boston Millennia Partners portfolio company, CardioMEMS, CEO & Founder, Dr. Jay Yadav was named Ernst & Young Entrepreneur of the Year in the health sciences catagory. Learn More >
< Previous	Next >

Odyssey Logistics & Technology Year-Over-Year Revenues Through May Up 93 Percent Boston Millennia portfolio Company Odyssey Logistics & Technology has announced that top line revenues in 2011 grew 93 percent through May when compared with the same period a year ago. Learn More >
< Previous	Next >

Boston Millennia Strategic Partner PAREXEL signs agreement with Pfizer Boston Millennia Strategic Partner, PAREXEL International Corp., has announced that it has been selected to become a strategic partner with Pfizer, Inc. to provide clinical development services. Learn More >
< Previous	Next >

CardioMEMS Founder & CEO Dr. Jay Yadav Named Ernst & Young Entrepreneur of the Year Finalist Dr. Jay Yadav, founder and CEO of CardioMEMS, a Boston Millennia Partners portfolio company, was named Ernst & Young Entrepreneur of the Year Finalist. Dr. Yadav founded CardioMEMS to develop devices for the treatment of chronic cardiovascular diseases. Learn More >
< Previous

Click Here to receive news updates
from Boston Millennia Partners >

	Video: Click Here to View
	Video: Large \| Small
	Video: Large \| Small


			Healthcare information is becoming broadly available to consumers, which is expanding basic demand. Learn More >

			Three key areas of opportunity in the Life Sciences sector are drug discovery & development... Learn More >

|

Our Firm Our Team Our Portfolio Resources News

© 2008 Boston Millennia Partners All Rights Reserved